Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Competitors and Similar CompaniesClear all

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical's competitors and similar companies include GeneDx, Ginkgo Bioworks Holdings and Poseida Therapeutics.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical is a company that manufactures biomedicine.
GeneDx
GeneDx
GeneDx is a company operating in the genetics and genomics industry.
Ginkgo Bioworks Holdings
Ginkgo Bioworks Holdings
Ginkgo Bioworks Holdings is a company that designs and develops genetic technology solutions.
Poseida Therapeutics
Poseida Therapeutics
Poseida Therapeutics utilizes best-in-class genome engineering capabilities to develop targeted lifesaving therapeutics.
Founding Date
Founding Date
1996
Founding Date
2000
Founding Date
2020
Founding Date
2015
Type
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
CN HQ
Locations
Gaithersburg, US HQ
Locations
Boston, US HQ
Locations
San Diego, US HQ
Employees
Employees
921
Employees
8964% increase
Employees
1,2186% decrease
Employees
3111% decrease

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$170.2m (FY, 2025)
Revenue (est.)
$64.7m (FY, 2023)
Net income
Net income
N/A
Net income
N/A
Net income
($312.8m) (FY, 2025)
Net income
($123.4m) (FY, 2023)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 789.1m
Total funding raised
$ 336.5m
For sources of this data, please see the company profile

View Company Profiles

GeneDx
HQ
Gaithersburg, US

GeneDx is a company operating in the genetics and genomics industry.

View company
Ginkgo Bioworks Holdings
HQ
Boston, US
Employees
1,218↓ 6% decrease

Ginkgo Bioworks Holdings is a company that designs and develops genetic technology solutions.

View company
Poseida Therapeutics
HQ
San Diego, US
Employees
311↓ 1% decrease

Poseida Therapeutics utilizes best-in-class genome engineering capabilities to develop targeted lifesaving therapeutics.

View company